2009-2014
Piush Vidyarthi founded the company in 2009. The company was privately funded by the founders. The initial model was to buy and sell products to raise enough money to develop our own products. Our first commercial product for women’s health was in 2014: SonoSure, SonoHysterogrophy and Endometrial Sampling Device. We licensed the US distribution rights for this device to Norgenix Pharmaceuticals.

2015-2018
CrossBay received US and EU clearances for SonoFlow, Sonohysterography and Sonohysterosalpingography Device. The distribution rights for the product was also licensed to Norgenix Pharmaceuticals. Unfortunately, it was only a short while later that Norgenix Pharmaceuticals closed it doors.

During this period, CrossBay was working on a new technology for what is now CrossGlide™. The company received US and EU clearances for the first product using CrossGlide™ technology in 2017. This product was called the CrossBay IVF Embryo Transfer Catheter Set.
View Press Release

In 2018, the company licensed this product and its related IP to Vitrolife AB.
View Press Release

Additionally in 2018, the company licensed its second product for cervical dilator using CrossGlide™ to Hologic, Inc. This product was to be co-developed with Hologic, Inc.

2019-Present
Hologic released to market Definity, for cervical dilation. CrossBay is now focused on bringing additional products to market using CrossGlide™. We received European clearance for the CrossBay Endometrial Tissue Sampler (ETS) in June, 2019.

Hologic Launches Definity Cervical Dilator to Provide Gentle and Seamless Dilation During Gynecologic Procedures

Contact supplier